... Fiber scaffolds have received increasing interest as promising biomaterials for potential application in the field of tissue regeneration. In this sense, we optimized the parameters for the synthesis of different ...
... Mesenchymal stem cells (MSC) are adult stem cells typically obtained from different sources (including bonemarrow) and they have multilineage potential in vitro. Because they are able to undergo ...
... Background. The interests in mesenchymal stem cells (MSCs) and their application in cell therapy have resulted in a better understanding of the basic biology of these cells. Recently hypoxia has been indicated as crucial ...
... Mesenchymal stem cells promising role in cell-based therapies and tissue engineering appears to be limited due to a decline of their regenerative potential with increasing donor age. Six age groups from bone ...
... Cells from the mesenchymal and epithelial regions of the amnion can be isolated easily. Different methods to isolate HAM-derived cells have been published (Dazzi and Marelli-Berg, 2008, Parolini et al., 2008, Alviano et ...
... evaluated bonemarrow aspirate, chimerism lymphocyte subpopulations, im- munoglobulins, Karnofsky/Lansky score according to age, post-transplantation complications, current sta- tus, time of follow-up, and ...
... or bonemarrow transplant from an HLA-identical ...International BoneMarrow Transplant Registry Working Committee on Alternative Donor and Stem Cell ...
... comparison. Bonemarrow core biopsy specimens per- formed for staging of lymphomas, to rule out metastatic disease, or for work-up of non-neoplastic conditions whose final in- terpretation was negative for ...
... their diverse potentialities to differentiate into specific functional cell types to regenerate damaged optic nerves, supporting tissues and vasculature. They will use clinical grade purification system (CliniMACS) and ...
... Therapeutic approaches for CKD (chronic kidney disease) have been able to reduce proteinuria, but not diminish the disease progression. We have demonstrated beneficial effects by injection of BM (bone ...
... Our transplantation program started in January 2015 a non-CRYO model in patients with MM and LYMPH in order to avoid a possible DMSO toxicity and cryopre- servation costs; the preliminary information from this strategy ...
... of bonemarrow transplantation in patients with malignant haemopa- thies and bonemarrow failure syndromes; that is, their use was exclusive for their clinical application, restricted to the ...
... expression of OC it was obtained at 7 days of culture, which is an early expression for this protein. These results correlate well with other studies using rat MSC isolated from bonemarrow. These cells ...
... Es el proceso por el cual se produce la proliferación y diferenciación de células mesenquimales hacia aquellas células formadoras de hueso (Urist y cols, 1965). La osteoinducción por parte de los injertos mineralizados ...